Literature DB >> 24482183

RANKL-based osteoclastogenic assays from murine bone marrow cells.

Lianping Xing1, Brendan F Boyce1.   

Abstract

Osteoclasts are the only cell type in the body to resorb bone. Osteoclasts play a critical role in physiologic and pathologic bone remodeling. Many genetic mouse models affect the skeleton by regulating osteoclast function directly or indirectly. This protocol describes a procedure for generating osteoclasts from mouse bone marrow cells using macrophage colony stimulating factor and receptor activator of NF-κB ligand.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24482183     DOI: 10.1007/978-1-62703-989-5_23

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Osteoclast derivation from mouse bone marrow.

Authors:  Ruth Tevlin; Adrian McArdle; Charles K F Chan; John Pluvinage; Graham G Walmsley; Taylor Wearda; Owen Marecic; Michael S Hu; Kevin J Paik; Kshemendra Senarath-Yapa; David A Atashroo; Elizabeth R Zielins; Derrick C Wan; Irving L Weissman; Michael T Longaker
Journal:  J Vis Exp       Date:  2014-11-06       Impact factor: 1.355

2.  Osteoclast precursors do not express CD68: results from CD68 promoter-driven RANK transgenic mice.

Authors:  Melissa F Jackson; Marta Scatena; Cecilia M Giachelli
Journal:  FEBS Lett       Date:  2017-02-20       Impact factor: 4.124

3.  Histone deacetylase 5 is a phosphorylation substrate of protein kinase D in osteoclasts.

Authors:  Carina Mello Guimaraes Meyers; Samuel D Burciaga; Bora Faulkner; Parandis Kazemi; Jacob M Cohn; Kim C Mansky; Eric D Jensen
Journal:  Bone       Date:  2022-03-19       Impact factor: 4.626

Review 4.  Osteoclasts-Key Players in Skeletal Health and Disease.

Authors:  Deborah Veis Novack; Gabriel Mbalaviele
Journal:  Microbiol Spectr       Date:  2016-06

5.  A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation.

Authors:  Qinggang Dai; Yujiao Han; Furong Xie; Xuhui Ma; Zhan Xu; Xiao Liu; Weiguo Zou; Jun Wang
Journal:  J Vis Exp       Date:  2018-03-15       Impact factor: 1.355

6.  Trabecular Bone Deficit and Enhanced Anabolic Response to Re-Ambulation after Disuse in Perlecan-Deficient Skeleton.

Authors:  Ashutosh Parajuli; Shaopeng Pei; Hongbo Zhao; Jerahme R Martinez; X Lucas Lu; X Sherry Liu; Mary C Farach-Carson; Catherine B Kirn-Safran; Liyun Wang
Journal:  Biomolecules       Date:  2020-01-29

7.  Regulation of Osteoclast Differentiation at Multiple Stages by Protein Kinase D Family Kinases.

Authors:  Amanda C Leightner; Carina Mello Guimaraes Meyers; Michael D Evans; Kim C Mansky; Rajaram Gopalakrishnan; Eric D Jensen
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

8.  Conditional Controlled Light/Dark Cycle Influences Exercise-Induced Benefits in a Rat Model with Osteoarthritis: In Vitro and In Vivo Study.

Authors:  Yunkyung Hong; Seunghoon Lee; Jeonghyun Choi; Yunho Jin; Jinyoung Won; Yonggeun Hong
Journal:  J Clin Med       Date:  2019-11-02       Impact factor: 4.241

9.  TRAF6/ERK/p38 pathway is involved in interleukin-17-mediated autophagy to promote osteoclast precursor cell differentiation.

Authors:  Yeqi Shen; Zhongxiu Wang; Jingyi Tan; Jiahui Zhong; Lili Chen
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-04-25

10.  Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages.

Authors:  Lu Song; Jingyi Tan; Zhongxiu Wang; Peihui Ding; Qi Tang; Mengjiao Xia; Yingming Wei; Lili Chen
Journal:  Mol Med Rep       Date:  2019-04-11       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.